Bayesian Capital Management, LP Vanda Pharmaceuticals Inc. Transaction History

Bayesian Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $90,158 - $138,397	21,065 New	21,065 $91,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $123,000 - $275,520	-16,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $203,032 - $286,508	16,400 New	16,400 $269,000
Q2 2019 Aug 13, 2019	SELL	$13.37 - $18.85 $175,147 - $246,935	-13,100 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$17.59 - $31.05 $102,022 - $180,090	-5,800 Reduced 30.69%	13,100 $241,000
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $136,584 - $226,584	-7,200 Reduced 27.59%	18,900 $494,000
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $260,975 - $328,900	14,300 Added 121.19%	26,100 $599,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $164,610 - $225,969	11,800 New	11,800 $225,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.